Cardioprotection for 20 Years for Children With Cancer
A case is building for the routine use of dexrazoxane to protect the hearts of children with cancer being treated with doxorubicin.
Source: medscape.com
Stay updated with breaking news from Eft Ventri. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A case is building for the routine use of dexrazoxane to protect the hearts of children with cancer being treated with doxorubicin.
Most children with multisystem inflammatory syndrome related to COVID-19 infection show recovery of cardiac function by 3 months.